ConKay Medical Systems Raises $1.8M in Oversubscribed Seed Funding Round
PLEASANTON, Calif.–(BUSINESS WIRE)–ConKay Medical Systems, a medtech start-up company developing a unique device for treating patients suffering from valvular regurgitation, has closed an oversubscribed $1.8M seed round. Multiple investment funds participated in the round including Unorthodox Ventures, SCP Ventures, WS Investment Company, and individual angel investors. “ConKay’s innovative technology addresses a significant unmet need experienced by tens of millions of patients,” said Unorthodox Ventures Founder Carey Smith. “We’re pleased to support the company as it heads toward first-in-human clinical trial.”
